Neuroendocrine Responses in Major Depression

  • P. Rogue
  • J. P. Macher
  • R. Minot
  • F. Duval
  • M. A. Crocq
  • F. Fleck
Chapter

Abstract

Various neuroendocrine abnormalities have been reported in depressives as a group (see for review Kalin and Dawson, 1986). The way they relate to the aetiology of depression remains unknown. Yet there must be some form of association between these alterations. The use of a battery of neuroendocrine tests, whereby multiple hormonal responses to a series of challenges are measured in the same patients, allows the study of these interrelationships. Through this strategy an increased variability in neuroendocrine responsiveness (Amsterdam et al., 1983), and the presence of more abnormalities in patients with a positive familial history (Rogue et al., 1985), have been evidenced in major depression.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. Amsterdam, J.D., Winokur, A., Lucki, I., Caroff, S., Snyder, P., and Rickeis, K. (1983). A neuroendocrine test battery in bipolar patients and healthy controls. Archives of General Psychiatry, 40, 515–21.CrossRefPubMedGoogle Scholar
  2. Carroll, B.J., Feinberg, M., Greden, J.F., Tarika, J., Albala, A.A., Haskett, R.F., James, N., Kronfol, Z., Lohr, N., Steiner, M., de Vigne, J.P., and Young, E. (1981). A specific laboratory test for the diagnosis of melancholia. Standardization, validation and clinical utility. Arch. Gen. Psychiatry, 38, 15–22.CrossRefPubMedGoogle Scholar
  3. Charney, D.S., Heninger, G.R., Steinberg, D.E., Hafstad, K.M., Giddings, S., and Landis, D.H., (1982). Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects. Arch. Gen. Psychiatry, 39, 290–4.CrossRefPubMedGoogle Scholar
  4. Janowsky, A., Okada, F., Manier, D.H., Applegate, C.L., Sulzer, F.E., and Steranka, L.R. (1982). Role of serotoninergic input in the regulation of the adrenergic receptor-coupled adenylate cyclase system. Science, 218, 900–1.CrossRefPubMedGoogle Scholar
  5. Kalin, N.H., Dawson, G. (1986). Neuroendocrine dysfunction in depression: hypothalamic-anterior pituitary systems. Trends in Neuroscience, 9, 261–6.CrossRefGoogle Scholar
  6. Matussek, N., Ackenheil, M., Hippius, H., Muller, F., Schroder, H.T.H., Schultes, H., and Wasilewski, B. (1980). Effects of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Res., 2, 25–36.CrossRefPubMedGoogle Scholar
  7. Meltzer, H.Y., Umberkoman-Witta, B., Robertson, A., Tricou, B.J., and Perline, R. (1984). Effects of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. Arch. Gen. Psychiatry, 41, 366–74.CrossRefPubMedGoogle Scholar
  8. Meltzer, H.Y., Umberkoman-Witta, B., Robertson, A., Tricou, B.J., and Perline, R. (1986). Correction and amplification: cortisol responses to 5-HTP. Arch. Gen. Psychiatry, 43, 815.Google Scholar
  9. Piletz, J.E., Schubert, D.S., and Halaris, A. (1986). Evaluation of studies on platelet alpha 2-adrenoreceptors in depressive illness. Life Sciences, 39, 1589–1616.CrossRefPubMedGoogle Scholar
  10. Price, L.H.,Charney,D. S., Rubin, A.L., and Heninger, G.R. (1986). α2-adrenergic receptor function in depression. The cortisol response to yohimbine. Arch. Gen. Psychiatry, 43, 849–58.CrossRefPubMedGoogle Scholar
  11. Pilc, A., Enna, S.J. (1986). Antidepressant administration has a differential effect on rat brain α2-adrenoreceptor sensitivity to agonists and antagonists. Eur. J. of Pharmacol., 132, 277–82. Science, 230, 323–5.Google Scholar
  12. Rogue, P., Duval, F., Crocq, M.A., Minot, R., Macher, J.P., Gindein, J., and Fleck, F. (1985). Genetic aspects of the responses to a neuroendocrine test battery in affective illness. In Abstr. Assn Européenne de Psychiatrie, 2nd Annual Meeting, Strasburg, 1985.Google Scholar
  13. Siever, L.J., Uhde, T.W., Silberman, E.K., Jimerson, D.C., Aloi, J.A., Post, R.M., and Murphy, D.L. (1982). The growth hormone response as a probe of noradrenergic responsiveness in affective disorder patients and controls. Psychiatry Res., 6, 171–183.CrossRefPubMedGoogle Scholar
  14. Siever, L.J., Uhde, T.W., Jimerson, D.C., Post, R.M., Lake, R., and Murphy, D.L. (1984a). Plasma cortisol responses to clonidine in depressed patients and controls. Arch. Gen. Psychiatry, 41, 63–8.CrossRefPubMedGoogle Scholar
  15. Siever, L.J., Murphy, D.L., Slater, S., de la Vega, E., Lipper, E. (1984b). Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotoninergic responsivity in depression. Life Sciences, 34, 1029–39.CrossRefPubMedGoogle Scholar
  16. Siever, L.J., Davis, K.L. (1985). Overview; toward a dysregulation hypothesis of depression. Am. J. Psychiatry, 142, 1017–31.CrossRefPubMedGoogle Scholar
  17. Stockmeier, C.A., Martino, A.M., and Kellar, K.J. (1985). A strong influence of serotonin axons on β-adrenergic receptors in rat brain. Science, 230, 393–5.CrossRefGoogle Scholar
  18. Van Praag, H.M. (1987). Measuring central serotoninergic function via the ‘neuroendocrine window’. Actualities Psychiatriques (in press).Google Scholar
  19. Willner, P. (1985). Antidepressants and serotonergic neurotransmission: an integrative review. Psychopharmacol., 85, 387–404.CrossRefGoogle Scholar

Copyright information

© The Editors and the Contributors 1988

Authors and Affiliations

  • P. Rogue
  • J. P. Macher
  • R. Minot
  • F. Duval
  • M. A. Crocq
  • F. Fleck

There are no affiliations available

Personalised recommendations